Global Small Lymphocytic Lymphoma Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 3.08 Billion |
 Market Size (Forecast Year) |
USD 3.90 Billion |
 CAGR |
% |
| Major Markets Players |
全球小淋巴细胞淋巴瘤市场，按症状（颈部、腋窝或腹股沟无痛肿胀、发烧、疲劳、盗汗、体重减轻、食欲不振）、诊断（体检、血液检查、影像学研究、免疫表型分析、活检）、治疗（化疗、靶向治疗、干细胞移植、单克隆抗体治疗等）、剂量（药片、胶囊、注射剂等）、给药途径（口服、肠外、其他）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他）– 行业趋势和预测到 2029 年。
市场分析和规模
近年来，预计小淋巴细胞淋巴瘤市场将在预测期内快速增长。非霍奇金淋巴瘤和小淋巴细胞淋巴瘤 (SLL) 白血病是非霍奇金淋巴瘤的一种。这种癌症进展缓慢。许多患有小淋巴细胞淋巴瘤的人没有任何体征或症状。小淋巴细胞淋巴瘤 (SLL) 和慢性淋巴细胞淋巴瘤 (CLL) 之间的主要区别在于癌细胞针对的是免疫系统的哪个部分。由于医学的进步，SLL 的 5 年生存率有所提高。
Data Bridge Market Research 分析称，小淋巴细胞淋巴瘤市场在 2021 年的价值为 30.75 亿美元，预计到 2029 年将达到 39 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 3.00%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
市场定义
小淋巴细胞淋巴瘤 (SLL) 是一种疾病，当您的身体产生过多异常的 B 淋巴细胞（一种白细胞）时就会发生。B 淋巴细胞在正常运作时有助于抵抗感染。这些淋巴细胞会在您的小淋巴结（一种通过淋巴系统将有害物质过滤出体外的腺体）中积聚并增加 SLL。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
Symptoms (Painless Swelling in Neck, Armpit, or Groin, Fever, Fatigue, Night Sweats, Weight Loss, Loss of Appetite), Diagnosis (Physical Exam, Blood Tests, Imaging Studies, Immunophenotyping, Biopsy), Treatment (Chemotherapy, Targeted Therapy, Stem Cell Transplant, Monoclonal Antibody Therapy, Others), Dosage (Tablet, Capsule, Injections, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Amgen Inc. (US), Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (US), Merck & Co., Inc. (US), DAIICHI SANKYO COMPANY, LIMITED (Japan), AbbVie Inc. (US), Thermo Fisher Scientific Inc. (US), Teva Pharmaceutical Industries Ltd.( Israel), Abbott (US), Astellas Pharma Inc. (Japan), Merck KGaA (Germany), Allergan (Ireland) |
|
Market Opportunities |
|
Small Lymphocytic Lymphoma? Market Dynamics
Drivers
- Increasing prevalence of small lymphocytic lymphoma?
The rising prevalence of small lymphocytic lymphoma ?is anticipated to propel the market's growth rate. Along with this, the rising population with weak immune systems is estimated to influence the market dynamics as people with weak immune systems are at high risk of getting small lymphocytic lymphoma.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of small lymphocytic lymphoma? market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the small lymphocytic lymphoma? market. Additionally, high disposable income and increasing incidences of HIV/AIDS will expand the small lymphocytic lymphoma? market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the small lymphocytic lymphoma? market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the small lymphocytic lymphoma? market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the treatment? will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the small lymphocytic lymphoma? market. Additionally, complications linked with small lymphocytic lymphoma and lack of awareness among people will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This small lymphocytic lymphoma? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the small lymphocytic lymphoma? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Small lymphocytic lymphoma (SLL) accounts for about 7% of all Non-Hodgkin lymphomas in the United States, accounting for 14,000 new diagnoses and 4,000 deaths per year.
Small lymphocytic lymphoma? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, and adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Small Lymphocytic Lymphoma? Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery, while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, and inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of small lymphocytic lymphoma in recent months.
Recent Development
- In June 2020, BeiGene, Ltd. Had announced the launch of BTK inhibitor named BRUKINSA (zanubrutinib). It had received approval from the China National Medical Products Administration (NMPA). This medication is used in the treatment of adult patients suffering from chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and also employed in treating adult patients who have mantle cell lymphoma (MCL) and who have received at least one prior therapy.
Global Small Lymphocytic Lymphoma? Market Scope
The small lymphocytic lymphoma? market is segmented on the basis of symptoms, diagnosis, treatment, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Symptoms
- Painless Swelling in Neck, Armpit, or Groin
- Fever
- Fatigue
- Night Sweats
- Weight Loss
- Loss of Appetite
On the basis of symptoms, the small lymphocytic lymphoma market is segmented into painless swelling in neck, armpit, or groin, fever, fatigue, night sweats, weight loss, loss of appetite and others.
Diagnosis
- Physical Exam
- Blood Tests
- Imaging Studies
- Immunophenotyping
- Biopsy
On the basis of diagnosis, the small lymphocytic lymphoma market is segmented into physical exam, blood tests, imaging studies, immunophenotyping, and biopsy. Imaging studies segment is further segmented into computed tomography (CT) scan, x-ray, and positron emission tomography (PET).
Treatment
- Chemotherapy
- Targeted Therapy
- Stem Cell Transplant
- Monoclonal antibody therapy
- Others
On the basis of treatment, the small lymphocytic lymphoma market is segmented into chemotherapy, targeted therapy, stem cell transplant, monoclonal antibody therapy, and others. The segment of monoclonal antibody therapy is further segmented into alemtuzumab, brentuximab vedotin, ibritumomab tiuxetan, obinutuzumab, polatuzumab vedotin, ofatumumab, rituximab and tafasitamab.
Dosage
- Tablet
- Capsule
- Injections
- Others
On the basis of dosage, the small lymphocytic lymphoma? market is segmented into tablet, capsule, injections, and others.
Route of Administration
- Oral
- Parenteral
- Others
The route of administration segment for the small lymphocytic lymphoma? market is segmented into oral, parenteral, and others.
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
On the basis of end-users, the small lymphocytic lymphoma? market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
On the basis of distribution channel, the small lymphocytic lymphoma? market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Small Lymphocytic Lymphoma? Market Regional Analysis/Insights
The Small lymphocytic lymphoma? market is analysed and market size insights and trends are provided by country, symptoms, diagnosis, treatment, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Small lymphocytic lymphoma? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the small lymphocytic lymphoma? market because of the growing number of research and development activities in this region. Additionally, the growing presence of major key players will further propel themarket's growth rate in this region.
Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Small Lymphocytic Lymphoma? Market Share Analysis
小淋巴细胞淋巴瘤市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用优势。以上提供的数据点仅与公司对小淋巴细胞淋巴瘤市场的关注有关。
小淋巴细胞淋巴瘤市场的一些主要参与者是：
- 安进公司 (美国)
- 赛诺菲（法国）
- 诺华公司（瑞士）
- 辉瑞公司（美国）
- 葛兰素史克公司 (英国)
- 拜耳公司（德国）
- 阿斯利康（英国）
- 强生私人有限公司（美国）
- 礼来公司 (美国)
- F. Hoffmann-La Roche Ltd.（瑞士）
- 百时美施贵宝公司 (美国)
- 默克公司（美国）
- 第一三共株式会社（日本）
- AbbVie Inc.（美国）
- 赛默飞世尔科技公司（美国）
- Teva Pharmaceutical Industries Ltd.（以色列）
- 雅培（美国）
- 安斯泰来制药有限公司 (日本)
- 默克集团（德国）
- 艾尔建（爱尔兰）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
